Please login to the form below

Not currently logged in
Email:
Password:

Wilmington Healthcare appoints managing director

Gareth Thomas joins the healthcare intelligence provider

Wilmington Healthcare Gareth ThomasUK-based Wilmington Healthcare has appointed Gareth Thomas as its managing director.

In his new role, Thomas will have responsibility for driving growth and integration in Wilmington Healthcare's four brands, Binley's, NHiS, OnMedica and Wellards.

Thomas moves to the healthcare intelligence provider from Informa, where he joined as European sales director in 2012 before promotion to his most recent role as director of global key accounts.

Previously, Thomas served as international development director for Doctors.net.uk - part of the M3 Group - and was responsible for setting up global physician online community alliance Networks in Health.

He also brings experience from pharmaceutical CRM and data provider Cegedim, where he was vice president for North Europe, and IMS Health, where he served as marketing director for global services.

Richard Adams, director of the Insight division at parent company Wilmington plc, said: “Gareth has a wealth of experience in sales and marketing for pharmaceutical and healthcare industries in the UK and overseas.

“We are delighted to welcome him to our company, where he will play a key role in helping us to realise our ambition to become a market leader in intelligence-led healthcare.”

25th July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...